Wikidata

(Q43279239)

English

5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103).

scientific article published in October 2009

In more languages
default values for all languages
No label defined

No description defined

Statements

title
5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103). (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
author name string
John H Hutchinson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
Jeannie M Arruda
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
Christopher Baccei
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
Janice Darlington
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
Christopher D King
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
Pat Prodanovich
series ordinal
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017
Angelina Santini
series ordinal
14
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19739647
retrieved
18 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43279239&oldid=1606988906"